Reading, United Kingdom

Steven Boakes

This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Spero Therapeutics, Inc., New Pharma Licence Holdings Limited. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven Boakes. Retrieved from https://idiyas.com/inventor/steven-boakes-t739vrvt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Steven Boakes: Innovator in Polymyxin Compounds

Introduction

Steven Boakes is a notable inventor based in Reading, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of polymyxin compounds. With a total of 4 patents to his name, Boakes has focused on innovative methods for treating bacterial infections.

Latest Patents

One of his latest patents is titled "Polymyxin compounds and uses thereof." This invention provides a compound of formula (I) and its use in methods of treatment, including the treatment of bacterial infections. The patent outlines methods for the preparation of the compound, which has a specific structure involving various amino acid residues. Another significant aspect of this patent is the provision of pharmaceutical compositions comprising the compounds of formula (I) and their application in treating microbial infections.

Career Highlights

Throughout his career, Steven Boakes has worked with several companies, including Spero Therapeutics, Inc. and New Pharma Licence Holdings Limited. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Steven has collaborated with notable professionals in his field, including Pamela Brown and Michael Dawson. These partnerships have likely enhanced his research and innovation efforts.

Conclusion

In summary, Steven Boakes is a distinguished inventor whose work in polymyxin compounds has the potential to impact the treatment of bacterial infections significantly. His contributions to the pharmaceutical industry are noteworthy and reflect his commitment to innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…